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Patients with a known abdominal aortic aneurysm (AAA)
requiring treatment face a difficult decision-making process.
Although supported by general practitioners, specialists and
family caregivers in their task, the prospect of undergoing
surgical treatment for an asymptomatic disease with un-
predictable progression is not desirable, at best.
Open surgical (OPEN) repair has been described in many
instances as a painful, physically and psychologically de-
manding procedure, requiring a long and uncomfortable
recovery.1e3 The advent of endovascular repair (endovas-
cular aneurysm repair, EVAR) could have switched this
perception, leading the patients to a better attitude
towards an intervention with a much lesser degree of
invasiveness; however, the quality of life and other specific
requirements of EVAR, namely the necessity of a close and
more burdensome follow-up and an increased risk of re-
intervention within few years, causes patients concern,
with no significant improvement of quality of life after
EVAR compared with OPEN intervention.2,3 The two avail-
able interventions are different in several aspects related
to safety, effectiveness and treatment burden. Further-
more, in an era of economic constraints, the cost of
treatment is a further aspect that might interact with the
other treatment characteristics, together with patients’
condition and concerns, in determining the final decision.
Finally, other personnel could influence patient decision
making, such as patients’ relatives, carers and, of course,
medical staff.
Although some studies have investigated which treat-
ment options or their characteristics could be considered
relevant by patients facing the problem of the choice of
AAA treatment,4e7 a number of issues still remained unre-
solved. Specifically, the relative importance (RI) of each
characteristic of the treatment available, the possible
influence of cost and the attitude of the different subjects
involved in the treatment other than patients (surgeons and
patients’ relatives) have been not analysed before in
a large group of responders.
The objective of this study was to quantify and compare
the RI (value) assigned to the characteristics of the AAA
treatment options by vascular surgeons, AAA patients and
their family caregivers (i.e., a relative, a partner or a friend
involved in the patient’s assistance) depending on their
experience with treatment.
Methods
Study design and data collection
We conducted an observational, multicentre preferences
study adopting the technique of discrete choice analysis
(DCA).Over the past 15 years, the framework of DCA has been
increasingly using to elicit preferences for health-care
interventions, and to simultaneously value health benefits
and patient experience factors.8
The theory of DCA assumes that the value placed on
medical treatments is related to their characteristics
(e.g., risk of complications, invasiveness and time to
recovery). To know the value of treatments for AAA, in this
study, the participants were presented with a selected
number of hypothetical treatment scenarios. Each scenario
was described by six characteristics, each selected from
those of OPEN or EVAR; however, the resulting scenario
never corresponded exactly to either EVAR or OPEN. With
a discrete choice experiment, a factorial combination of
every six characteristic levels was performed to create
the hypothetical options.8 The different options were
combined into pairs (treatment A versus treatment B,
example shown in Fig. 1), and these were submitted to the
participants, who were asked to choose, within each pair,
the preferred option according to the characteristic levels’
combination. From the respondents’ choice between A and
B from each pair received, we calculated which treatment
characteristics can affect the preferences of the target
subjects, whether a characteristic is considered negative or
positive (direction of preferences) and how much one
characteristic is more important than the others (RI).
To create scenarios that were easily understood, we
selected a reasonable number of characteristics through
a preliminary study. First, a literature search was per-
formed to select all the treatment characteristics poten-
tially relevant to the target individuals. Second,
a discussion with a panel of experienced staff surgeons and
health economists with experience in the field of outcomes
research finalised the list of the characteristics potentially
relevant for the study purpose (Table 1). Third, a small pilot
survey was performed by submitting this list to six AAA
patients and seven experienced staff vascular surgeons,
who scored each characteristic according to the perceived
level of importance from 0 (“not important at all”) to 10
(“very important”). The five characteristics receiving
a mean higher level were selected (Table 2) and worded in
an easy-to-understand way. A sixth characteristic was
added to determine the possible role of the cost of the
intervention in the decision-making process. To meet the
different perception of the participants in the study,
patients and relatives were asked to consider a possible
out-of-pocket cost (Fig. 1(a)), while physicians were asked
to consider an additional procedural cost on the hospital
budget (Fig. 1(b)).
As the cognitive burden of eight pairs of treatments was
considered potentially too high for some patients’, the set
was split into two blocks: namely each patient received
only four possible scenarios, while the family caregivers
and physicians received all the eight pairs. Before these,
the participants received a description of the study
Figure 1 Example of choice set given to patients and family
caregivers (1a) and to physicians (1b).
28 G. Faggioli et al.objective, of the task to be performed and of the charac-
teristics shown in the treatment options.
Together with these tasks, the patients were also asked to
describe their own Health Related Quality of Life (HRQoL)
at enrolment in the study. Physicians were asked to re-
port patient’s demographic data, case history and clinical
characteristics (e.g., American Society of AnaesthesiologistsTable 1 Pilot study. Characteristics of AAA treatment evaluate
1 Type of anaesthesia
2 Length of hospital stay (number of days)
3 Need of intensive care
4 Recovery time (e.g., time to the first meal, stomach pump
5 Type of follow-up (CT scan, ultrasound scanning)
6 Need of follow-up medical visits and examinations during t
7 Risk of major perioperative procedural complications (myo
8 Risk of minor perioperative procedural complications (i.e.,
9 Recovery time to fully perform everyday activities, like wa
10 Risk of sexual function impairment
11 Position and dimension of scar
12 Risk of repetition of procedure
13 Need to wear a body belt for 2 or 3 months after the inter(ASA) class and presence of co-morbidities) and possible
previous AAA treatment.
To describe their HRQoL, the patients completed the
standard and widely used EQ-5D generic instrument.9 It
consists of two main parts: the first part generates a health
profile (EQ-5D profile) made of five domains, namely
‘mobility’, ‘self care’, ‘anxiety or depression’, ‘usual activ-
ities’ and ‘pain or discomforts’, each one with three levels of
severity (‘no problem’, ‘some or moderate problems’ and
‘extreme problems’). The second part of the questionnaire
consists of a visual analogue scale (EQ-5D VAS), measuring
overall HRQoL ranging from 0 (worst imaginable health
status) to 100 (best imaginable health status).
Subjects and setting
Nine vascular surgery units throughout Italy contributed to
the study (PREFER Study Group e listed in Appendix). The
clinical investigators at each hospital completed the dis-
crete choice questionnaire for reporting their own prefer-
ences. Then they enrolled up to 20 valid AAA patients
consecutively admitted into the hospital and their family
caregivers (i.e., a relative or a friend, who is involved and
assists the patient to manage his condition), who accom-
panied the patient at the visit. To be valid for the study, the
patients had to be assigned to either OPEN or EVAR, or
should have been previously submitted to either one,
according to clinical practice. Furthermore, to be able to
compare the responses according to patients’ and care-
givers’ experience with AAA treatment, each centre had to
balance the sample into four subgroups: patients not
treated and expecting to receive OPEN, those expecting to
receive EVAR, patients already treated with OPEN and
patients already treated with EVAR. The choice between
OPEN and EVAR was made according to each participants’
centre’s attitude and was independent of our study
protocol.
Untreated patients and their caregivers were also
asked to complete again the questionnaire, approximately
6 months after the procedure. Hence, these participants
expressed their preferences both before and after the
treatment. Accordingly, their preferences provided after the
treatment were analysed together with those obtained from
participants, who, at enrolment, were already treated.d.
, vesical catheter, drug therapy, time to start again walking)
he years after the intervention
cardial infarction, death)
wound complications)
shing and dressing)
vention
Table 2 AAA treatment characteristics with appropriate levels.
Attributes (labels) Levels (codes included in the logistic model)
Type of anaesthesia (ANAESTHESIA) Local (0)
General (1)
Time necessary to come back to do everyday activities after the intervention
(for instance washing and dressing) (RECOVERY)
2 days (2)
4 days (4)
Possible need to repeat the intervention within the next 5 years (REPEAT) In 7 out of 100 patients (0.07)
In 15 out of 100 patients (0.15)
Type of periodical exams and medical visits to perform after the
intervention (CHECKUP)
Clinical assessment, duplex scanning (0)
Clinical assessment, duplex scanning þ
CT scan (1)
Risk of severe procedural complications (even death) (COMPLICATIONS) In 2 out of 100 patients (0.02)
In 5 out of 100 patients (0.05)
Additional cost to received the interventiona (COST) 0 V (0)
2000 V (2000)
a Additional cost was differently hypothesised to patients and family caregivers (additional out-of-pocket cost to receive the treat-
ment) compared with physicians (additional cost on the hospital budget), as shown in Fig. 1.
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This study was conducted in agreement with the National
Regulatory Requirements, International Conference on
Harmonisation Guidelines for Good Clinical Practice and the
18th World Medical Assembly10 and all subsequent amend-
ments. The study protocol was submitted at each partici-
pating centre’s Ethical Committee. Each patient and family
caregiver had to sign an informed written consent to
participate.
Modelling and data analyses
Responses from the DCA were analysed using a conditional
binomial logistic regression model in STATA v.10.0.8 The
following model (1) was generated to analyse preferences
for each AAA treatment characteristic:
VZb1XANAESTHESIA þ b2XRECOVERY þ b3XREPEAT þ b4XCHECKUP
þ b5XCOMPLICATIONS þ b6XCOST ð1Þ
where V represents the overall value assigned to a given
treatment, and is function of the value assigned to each
characteristic level of that treatment, represented by Xs:
for example, XANAESTHESIA indicates the level of the char-
acteristic ‘type of anaesthesia to perform the procedure’,
general (coded as 1) or local (coded as 0) anaesthesia. All Xs
and the codes used in the regression model are defined in
Table 3.
In the model, the regression coefficients b1b6 identify
the estimates of the level of importance assigned to a unit
change of each treatment characteristic X, keeping equal
the other characteristic levels. For example, b1 indicates
the level of importance of general versus local anaesthesia
(XANAESTHESIA), b2 the level of importance of number of days
(2 versus 4) necessary to come back to basic autonomous
activities (XRECOVERY) and b6 is related to the importance
assigned to a 1V increase in additional treatment cost
(XCOST) on treatment value. The sign of the coefficients
indicates the direction of preferences, that is, whethera unit change in the characteristic level has a positive or
negative effect on respondents’ preferences: for instance,
a negative b1 indicates that a local anaesthesia is preferred
to a general one, while a positive sign indicates that local
anaesthesia is preferred; negative b2 and b3 indicate that
a reduced number of days until the recovery and of risk of
repeating the intervention within 5 years are preferred;
a negative b4 indicates that a less burdensome check-up,
which excludes the computed tomography (CT) examina-
tion, is preferred; and negative b5 and b6 indicate that
a reduced risk of complications and costs are preferred. A
bs with a p < 0.05 was considered statistically significant.
Finally, with the bs estimates obtained, we calculated the
RI assigned to each characteristic compared with the others
included in the treatment scenarios.
The model (1) was applied by subgrouping the partici-
pants according to their role and point of view in the
context, that is, if they were patients, caregivers or
physicians. Also, subgroups were created according to
patients’ and caregivers’ experience with the treatment,
that is, never treated versus already treated, and among
these, OPEN versus EVAR treatment received.
Results
Questionnaires were completed by 160 valid patients, 102
family caregivers (partners, children, siblings or friends)
and 30 physicians. Physicians intervened only in case of
difficulty in comprehension while completing the ques-
tionnaires. Table 3 shows the characteristics of the patients
at their enrolment into the study.
Among the 76 patients already treated at enrolment,
three underwent two interventions: one received two EVAR
procedures in 8 years and two received EVAR first and OPEN
after 2 and 3 years. Fifty-four of these 76 patients’ care-
givers reported their own preferences at enrolment. Among
the 84 untreated patients, 65 completed the questionnaire
also 6 months after the treatment, together with 30 of their
caregivers.
Table 3 Patients’ characteristics at their enrollment into
the study (N Z 160).
Variable description Values
Age Mean (minemax) 72.6
(49.3e88.1)
Gender
males 92.5%
Smoking habits
Ex smokers 65.3%
Current smokers 26.7%
Never smokers 8.0%
Past treatment of AAA
Patients already treated 47.5%
EVAR 52.6%
OPEN 47.4%
ASA Class
1 2.8%
2 28.7%
3 67.4%
4 1.4%
Concomitant diseases
Dyslipidemia 36.9%
Obesity (BMI > 31 kg/m2) 23.1%
Hypertension 80.8%
Non insulin dependent
diabetes mellitus
14.6%
Insulin dependent
diabetes mellitus
2.6%
Cardiac disease 46.0%
Cerebrovascular
disease
8.0%
Renal dysfunction/
disease (creatinine
levels > 2 mg/dl)
9.9%
Chronic Obstructive
Pulmonary Disease
38.3%
Quality of Life (EQ-5D)
Mobility No problem 64.5%
Some problems 35.5%
Confined to bed 0
Self care No problem 85.7%
Some problems 13.6%
Unable to do 0.6%
Usual activities No problem 77.4%
Some problems 20.0%
Unable to do 2.6%
Pain/discomfort None 60.3%
Some 38.5%
A lot 1.3%
Anxiety/depression None 65.6%
Some 29.2%
A lot 5.2%
VAS: mean (minemax) 70.3
(15e100)
30 G. Faggioli et al.Treatment was performed 0.9 (1.3 SD) years before in
EVAR patients and 1.6 (2.3 SD) in OPEN patients.
Overall, less than 10 patients refused to participate in
the study when asked to. Among all the participants,
98.9% of the treatment pairs distributed were answered,
(98.4% by patients, 99% by relatives and 100% by the
physicians) with a total of 2171 observations (choices)
obtained.
Major complications and re-intervention risk were
overall the most important characteristics (RI Z 56.0% and
27.2%, respectively) for all the respondent categories. The
risk of major complications was the most important treat-
ment characteristic for untreated patients, caregivers and
physicians (Table 4), with a RI of 32e43%. In contrast,
treated patients, and, in particular, those treated with
OPEN (Table 5), considered the cost the most important
characteristic, with a RI of 34.6%, while those treated with
EVAR confirmed their higher preferences for the risk of
procedural complication. On the other hand, the type of
treatment experienced did not change caregivers’ opinion
with regard to cost and procedural risk. An additional
hospital cost of the procedure was considered less impor-
tant (7% RI) than all but one characteristic (type of anaes-
thesia) by the physicians.
The risk of re-intervention was the second most impor-
tant characteristic among the physicians (RI Z 25%), and
the third most important one for treated (RIZ 22e23%) and
untreated (RI Z 12e13%) patients and caregivers. Accord-
ing to the type of treatment (Table 5), patients and care-
givers experiencing OPEN considered this risk more
important (RI Z 19e27%) than did subjects experiencing
EVAR (RI Z 17e20%).
The number of days to be back to basic everyday
activities was significant for the already treated patients
(RIZ 14.8%), regardless of the type of treatment received,
but not for untreated patients, family caregivers and
physicians (RI Z 6e9%).
Follow-up mode was not significant for any subgroup of
patients and caregivers (RI < 8%), while it was for the
physicians (RI Z 13%), more important than the recovery
time and the type of anaesthesia.
The type of anaesthesia was apparently not significant in
any subgroup of respondents, with a maximum RI of 8.7%.
However, when analysed separately, patients treated with
OPEN preferred general anaesthesia (RI Z 13.6%), while
those treated with EVAR significantly preferred local
anaesthesia, with an RI of 17%.
Discussion
Our study shows that a possible relative reduction of major
complication and mortality risk of 50% gets generally the
highest RI among patients with AAA, their caregivers and
physicians, compared with the other characteristics
considered in the treatment options. This result could be
considered not surprising and, taken alone, could let us
conclude that EVAR e which implies a lower procedural
risk e is always the preferred option in AAA treatment.
However, our study also shows that different aspects
interact in determining the overall value of the available
treatments, such as the risk of re-intervention at 5 years. If
this was considered less important by untreated patients,
Table 4 Results stratified according to the role/point of view and to the experience with treatment.
Sub-groups of
respondents
Patients Family caregivers Specialist physicians
Treatment Untreated Treated Of untreated patient Of treated patient
Characteristics b (p value) RI(%) b (p value) RI(%) b (p value) RI(%) b (p value) RI(%) b (p value) RI(%)
Anaesthesia 0.165 (0.174) 8.7 0.003 (0.972) 0.0 0.071 (0.535) 3.3 0.035 (0.697) 2.1 0.108 (0.544) 3.6
Recovery 0.084 (0.161) 8.8 0.110 (0.016) 14.8 0.079 (0.152) 7.3 0.050 (0.251) 5.9 0.116 (0.185) 7.6
Repeat 3.143 (0.038) 13.2 4.106 (0.000) 22.2 3.167 (0.027) 11.8 4.853 (0.000) 23.0 9.459 (0.000) 24.9
Check-up 0.109 (0.362) 5.7 0.057 (0.530) 3.8 0.168 (0.128) 7.8 0.121 (0.169) 7.2 0.397 (0.024) 13.1
Complications 20.767 (0.000) 32.8 11.335 (0.000) 22.9 31.229 (0.000) 43.6 19.768 (0.000) 35.1 43.996 (0.000) 43.4
Cost ( 1,000) 0.291 (0.000) 30.7 0.268 (0.000) 36.2 0.282 (0.000) 26.2 0.227 (0.000) 26.8 0.1123 (0.206) 7.4
No. of obs.
(choices)
334 550 431 614 240
No. of
respondentsc
84 141 54 78 30
Log Likelihooda 430.0
Adjusted
McFadden R2b
0.137
 Regression coefficients (bs) are computed for the difference between the levels of each treatment characteristic. For instance, b of “ANAESTHESIA” represents the relative importance
for moving from a local to a total anaesthesia to perform the intervention, every other characteristic assumed to be equal, while b of COST represents the relative importance for one unit
of change in cost, from 0 to 2000 V, every other characteristics being equal.
The sign indicates the direction of preferences: in case of “ANAESTHESIA” the negative sign means that respondents preferred a total (coded as 1) over a local anaesthesia (coded as 0);
regarding COST, the negative sign of coefficients means that respondents preferred a less expensive procedure over a more expensive one.
a Logistic regression uses maximum likelihood approach to estimate parameters.
b Pseudo R2 (McFadden R2) is a measure of the overall model goodness-of-fit.
c The number of respondents corresponds to the number of those reporting their preferences at each time of data collection (enrolment
versus follow-up), depending on their treatment experience (already treated versus still to be treated).
C
h
o
ice
o
f
A
b
d
o
m
in
a
l
A
o
rtic
A
n
e
u
rysm
s
T
re
a
tm
e
n
t
O
p
tio
n
s
31
Table 5 Results comparison according to type of treatment received, between patients and their family caregivers.
Sub-groups of respondents Treated patients Family caregivers of treated patients
Treatment OPEN EVAR OPEN EVAR
Characteristics b (p value) RI(%) b (p value) RI(%) b (p value) RI(%) b (p value) RI(%)
Anaesthesia 0.267 (0.041) 13.6 0.268 (0.044) 17.3 0.090 (0.475) 5.7 0.017 (0.892) 1.0
Recovery 0.121 (0.063) 12.3 0.095 (0.148) 12.3 0.071 (0.256) 9.0 0.032 (0.607) 3.6
Repeat 4.640 (0.004) 18.9 3.213 (0.054) 16.6 5.389 (0.001) 27.3 4.349 (0.006) 19.6
Check-up 0.167 (0.198) 8.5 0.063 (0.634) 4.1 0.169 (0.178) 10.7 0.076 (0.538) 0.5
Complications 7.952 (0.067) 12.1 13.041 (0.003) 25.3 15.328 (0.000) 29.1 24.188 (0.000) 40.9
Cost ( 1,000) 0.340 (0.000) 34.6 0.189 (0.004) 24.4 0.145 (0.021) 18.3 0.306 (0.000) 34.5
No. of obs. (choices) 292 258 289 325
No. of respondents 73 68 37 41
Log Likelihooda 1578.8
Adjusted McFadden R2b 0.520
Regression coefficients (bs) are computed for the difference between the levels of each treatment characteristic. For instance, b of
“ANAESTHESIA” represents the relative importance for moving from a local to a total anaesthesia to perform the intervention, every
other characteristic assumed to be equal, while b of COST represents the relative importance for one unit of change in cost, from 0 to
2000 V, every other characteristics being equal.
The sign indicates the direction of preferences: in case of “ANAESTHESIA” the negative sign means that respondents preferred a total
(coded as 1) over a local anaesthesia (coded as 0); regarding COST, the negative sign of coefficients means that respondents preferred
a less expensive procedure over a more expensive one.
a Logistic regression uses maximum likelihood approach to estimate parameters.
b Pseudo R2 (McFadden R2) is a measure of the overall model goodness-of-fit.
32 G. Faggioli et al.interestingly, it becomes similarly important to the risk of
procedural complications among treated patients, espe-
cially those who underwent OPEN surgery. This is reason-
able if we consider that patients are more concerned about
the risk attributable to the treatment before receiving it,
while this is no longer an issue after the procedure, when
they probably become more sensible to the risk of re-
intervention. However, a possible payment request was
considered very important to patients, suggesting that also
treatment costs would have a potential role in the decision-
making process. The issue of hypothetical cost is important
to further determine the small differences in patients’
overall perception between OPEN and EVAR procedures.
Although the possible fee indicated in the questionnaire
seemed to be reasonable in the proponents’ mind (2000 V),
it got the second highest RI level, which suggests that the
weight of this aspect is actually more important, compared
with others, than it could be expected. Clearly, that was
not the case for physicians, who were asked about an extra
cost to be paid by the hospital.
The recovery time and the type of anaesthesia were not
considered significantly important by physicians, caregivers
and untreated patients; differently, treated patients con-
sidered these two characteristics significantly important.
Gaining even one day of ability to perform basic everyday
activities was important to them, regardless of the type of
treatment experienced. Opposite opinions were found with
regard to the type of anaesthesia, between patients
treated with EVAR and those treated with OPEN; both
groups showed a preference towards the type of anaes-
thesia they actually experienced during the treatment,
which suggested an overall satisfaction with either method.
Finally, unlike the data of previous studies,2 the burden
of the follow-up procedure was not found to be a concern
to patients and caregivers.To understand patients’ preferences towards OPEN and
EVAR procedures, several methods of analysis have been
employed in the literature, such as in-depth interviews,
semi-structured interviews and questionnaire studies. In-
depth interviews are conventionally understood to have
a high degree of internal validity, and are considered to be
a qualitative approach for explaining phenomena that are
difficult to measure.11 Berman et al. applied this method to
patients undergoing AAA repair, collecting an interesting
scenario of patients’ opinions, thus highlighting the limi-
tations of contemporary informed consent. However, the
nature of these in-depth interviews neither allows to
collect a significant number of cases nor to quantify the
importance of the single treatment characteristics.4 In this
context, the opinion of nurses who assist patients with AAA
before and after treatment is indicative, but does not allow
a complete and unbiased analysis of the patients’ general
opinion about treatment.6 Other authors employed semi-
structured telephone interviews with a low response rate
(56 of 100 patients on an AAA surveillance programme),
determining that the risk of death was the main concern for
patients with AAA.5 Similarly, Reise et al. conducted
a postal survey and obtained a 70% response rate. In this
analysis, influence of medical advice reached the highest
importance among responders.7 As seen, the use of self-
administered questionnaires can gather information quickly
among a large number of participants, but postal surveys
may have limited significance and low participation rates.
The previous research examining endovascular versus sur-
gical treatment for coronary revascularisation used there-
fore more complex methods normally associated with
health economic analysis, such as time trade-off, gambling
and willingness-to-pay techniques.12
The type of analysis employed in the present study is
unique and straightforward in the analysis of treatment
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Choice of Abdominal Aortic Aneurysms Treatment Options 33choice regarding AAA. First, by obtaining preferences on
hypothetical treatment scenarios resulting from different
combinations of single treatment characteristics, it is
possible to precisely evaluate the relative importance of
each one of them. This would not be clearly possible by
simply asking an overall preference between the two treat-
ment options, namely EVAR and OPEN. Second, this method
allows us to obtain a large amount of data with a self-
completion procedure and to quantify the relative impor-
tance of each treatment characteristic that could influence
individuals’ choice. The self-completion approach allows
also minimising the presence of biases that could be present
from a direct interview approach. Moreover, not only did we
analyse the preferences of patientsewhich are clearly most
important in the treatment choice e but also those of both
family caregivers and physicians, who may influence
patients’ choices. Finally, a comparison of preferences
between subjects with different treatment experience was
possible, leading to additional information on how the
experience may change their opinion.
This study has some potential limitations, which should
be considered in further research. First, because prefer-
ences could depend also on the type of health-care system of
the different countries, our resultsmay be not generalised to
theworldwide target population. For instance, the cost issue
can be variably perceived in the different countries, with
diverse impacts on individuals’ perceptions and opinions.
Second, to produce cognitively efficient choice situations,
we did not analyse all treatment characteristics: the expo-
sure to radiation, nephrotoxicity of contrast medium and the
length of the procedure were not considered in the analysis,
as we opined the low risk associated with these factors could
be particularly difficult to be discussed with the average
educated patients and caregivers. Other aspects thatmay be
relevant to a number of patients, such as the length and
position of the scar and the possible sexual impairment (in
younger patients), were excluded according to the results of
the pilot study and considerations reached with the panel of
experts involved. This implies that we cannot exclude the
fact that other characteristics not analysed in this study may
be important to some specific categories of patients or in
other health-care systems. However, our study shows some
interesting results for subjects involved in the treatment of
AAA, different as regards their role and point of view, and
their past experience with the treatment. As the differences
in the results of EVAR and OPEN appear similar in the long
run,13 the choice between the two treatment methods may
rely on patients’ preferences, to suit their requirement, and
our results may be important in this sense.
In conclusion, the safety of the procedure is generally
considered the most important aspect of AAA treatment;
however, other treatment characteristics, apparently less
important, show high RI with different perceptions in
patients, their relatives and surgeons. These data should be
taken into consideration when informing patients under-
going AAA treatment, to obtain a complete and satisfactory
interaction with them.
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